SILVERARC CAPITAL MANAGEMENT, LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

Quarter-by-quarter ownership
SILVERARC CAPITAL MANAGEMENT, LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,246,000
+74.9%
350,000
+45.1%
4.62%
+71.5%
Q2 2023$8,715,026
+136.7%
241,213
+357.5%
2.70%
+116.3%
Q3 2022$3,682,000
-60.1%
52,720
-61.6%
1.25%
-56.1%
Q2 2022$9,217,000
+143.1%
137,303
+197.7%
2.84%
+80.8%
Q1 2022$3,792,000
-57.5%
46,122
-24.1%
1.57%
-56.6%
Q4 2021$8,912,000
+9.7%
60,757
+32.3%
3.61%
-21.4%
Q3 2021$8,127,000
+33.3%
45,941
+21.7%
4.60%
+68.9%
Q2 2021$6,098,000
+611.6%
37,753
+655.1%
2.72%
+482.4%
Q1 2021$857,000
-80.5%
5,000
-75.0%
0.47%
-81.7%
Q4 2020$4,393,00020,0002.55%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders